HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and safety concerns.
Latest Ratings for HIMS
DateFirmActionFromTo Mar 2022Deutsche BankInitiates Coverage OnHold Dec 2021CitigroupMaintainsBuy Dec 2021JefferiesInitiates Coverage OnHold